Fresh guidance to fill ‘information vacuum’ on new cannabis products for medicinal use


A clinical review, published for the BMJ, provides new interim advice for doctors and clinicians in prescribing cannabis-based products and cannabinoids to treat certain conditions. Since a policy change in November 2018, specialist doctors registered with the General Medical Council (GMC), have been permitted to prescribe new medicines which derive from cannabis.

Ga naar Bron